Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP)

Cellular Immunology

Volumn 259, Issue 1, 2009, Pages 82-89

  Rumble, Julie M ^a   Oetjen, Karolyn A ^a   Stein, Paul L ^b   Schwartzberg, Pamela L ^c   Moore, Bethany B ^a   Duckett, Colin S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Immunodeficiency; Signal transduction; Viral

Indexed keywords

SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; T LYMPHOCYTE ANTIGEN; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL MATURATION; CONTROLLED STUDY; GENE FUNCTION; HERPES VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; LYMPHOPROLIFERATIVE DISEASE; MOUSE; MOUSE STRAIN; NATURAL KILLER T CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; X CHROMOSOME LINKED DISORDER;

ANIMALS; ANTIBODY FORMATION; FIBROBLASTS; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOPROLIFERATIVE DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

ANIMALIA; HERPESVIRIDAE; MURINAE; MURINE HEPATITIS VIRUS; MUS;

EID: 68549107582     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.05.017     Document Type: Article

References (30)

1. Nichols K.E., Ma C.S., Cannons J.L., Schwartzberg P.L., and Tangye S.G. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease. Immunol. Rev. 203 (2005) 180-199
2. Hoffmann T., Heilmann C., Madsen H.O., Vindelov L., and Schmiegelow K. Matched unrelated allogeneic bone marrow transplantation for recurrent malignant lymphoma in a patient with X-linked lymphoproliferative disease (XLP). Bone Marrow Transplant. 22 (1998) 603-604
3. Purtilo D.T., Cassel C.K., Yang J.P., and Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1 (1975) 935-940
4. Nichols K.E., Harkin D.P., Levitz S., Krainer M., Kolquist K.A., Genovese C., Bernard A., Ferguson M., Zuo L., Snyder E., Buckler A.J., Wise C., Ashley J., Lovett M., Valentine M.B., Look A.T., Gerald W., Housman D.E., and Haber D.A. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA 95 (1998) 13765-13770
5. Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., Cahn A.P., Durham J., Heath P., Wray P., Pavitt R., Wilkinson J., Leversha M., Huckle E., Shaw-Smith C.J., Dunham A., Rhodes S., Schuster V., Porta G., Yin L., Serafini P., Sylla B., Zollo M., Franco B., Bolino A., Seri M., Lanyi A., Davis J.R., Webster D., Harris A., Lenoir G., de St Basile G., Jones A., Behloradsky B.H., Achatz H., Murken J., Fassler R., Sumegi J., Romeo G., Vaudin M., Ross M.T., Meindl A., and Bentley D.R. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genet. 20 (1998) 129-135
6. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G., Oettgen H., De Vries J.E., Aversa G., and Terhorst C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395 (1998) 462-469
7. Lewis J., Eiben L.J., Nelson D.L., Cohen J.I., Nichols K.E., Ochs H.D., Notarangelo L.D., and Duckett C.S. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family. Clin. Immunol. 100 (2001) 15-23
8. Sumegi J., Huang D., Lanyi A., Davis J.D., Seemayer T.A., Maeda A., Klein G., Seri M., Wakiguchi H., Purtilo D.T., and Gross T.G. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood 96 (2000) 3118-3125
9. Czar M.J., Kersh E.N., Mijares L.A., Lanier G., Lewis J., Yap G., Chen A., Sher A., Duckett C.S., Ahmed R., and Schwartzberg P.L. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl. Acad. Sci. USA 98 (2001) 7449-7454
10. Wu C., Nguyen K.B., Pien G.C., Wang N., Gullo C., Howie D., Sosa M.R., Edwards M.J., Borrow P., Satoskar A.R., Sharpe A.H., Biron C.A., and Terhorst C. SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nat. Immunol. 2 (2001) 410-414
11. Pasquier B., Yin L., Fondaneche M.C., Relouzat F., Bloch-Queyrat C., Lambert N., Fischer A., de Saint-Basile G., and Latour S. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201 (2005) 695-701
12. Chung B., Aoukaty A., Dutz J., Terhorst C., and Tan R. Signaling lymphocytic activation molecule-associated protein controls NKT cell functions. J. Immunol. 174 (2005) 3153-3157
13. Nichols K.E., Hom J., Gong S.Y., Ganguly A., Ma C.S., Cannons J.L., Tangye S.G., Schwartzberg P.L., Koretzky G.A., and Stein P.L. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11 (2005) 340-345
14. Cannons J.L., Yu L.J., Jankovic D., Crotty S., Horai R., Kirby M., Anderson S., Cheever A.W., Sher A., and Schwartzberg P.L. SAP regulates T cell-mediated help for humoral immunity by a mechanism distinct from cytokine regulation. J. Exp. Med. 203 (2006) 1551-1565
15. McCausland M.M., Yusuf I., Tran H., Ono N., Yanagi Y., and Crotty S. SAP regulation of follicular helper CD4 T cell development and humoral immunity is independent of SLAM and Fyn kinase. J. Immunol. 178 (2007) 817-828
16. Cannons J.L., Yu L.J., Hill B., Mijares L.A., Dombroski D., Nichols K.E., Antonellis A., Koretzky G.A., Gardner K., and Schwartzberg P.L. SAP regulates T(H)2 differentiation and PKC-theta-mediated activation of NF-kappaB1. Immunity 21 (2004) 693-706
17. Benoit L., Wang X., Pabst H.F., Dutz J., and Tan R. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165 (2000) 3549-3553
18. Gao N., Schwartzberg P., Wilder J.A., Blazar B.R., and Yuan D. B cell induction of IL-13 expression in NK cells: role of CD244 and SLAM-associated protein. J. Immunol. 176 (2006) 2758-2764
19. Chen G., Tai A.K., Lin M., Chang F., Terhorst C., and Huber B.T. Signaling lymphocyte activation molecule-associated protein is a negative regulator of the CD8 T cell response in mice. J. Immunol. 175 (2005) 2212-2218
20. Rigaud S., Fondaneche M.C., Lambert N., Pasquier B., Mateo V., Soulas P., Galicier L., Le Deist F., Rieux-Laucat F., Revy P., Fischer A., de Saint Basile G., and Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444 (2006) 110-114
21. Marsh R.A., Villanueva J., Zhang K., Snow A.L., Su H.C., Madden L., Mody R., Kitchen B., Marmer D., Jordan M.B., Risma K.A., Filipovich A.H., and Bleesing J.J. A rapid flow cytometric screening test for X-linked lymphoproliferative disease due to XIAP deficiency. Cytometry Part B (2009)
22. Marsh R.A., Villanueva J., Kim M.O., Zhang K., Marmer D., Risma K.A., Jordan M.B., Bleesing J.J., and Filipovich A.H. Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin. Immunol. 132 (2009) 116-123
23. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 (1997) 300-304
24. Harlin H., Reffey S.B., Duckett C.S., Lindsten T., and Thompson C.B. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21 (2001) 3604-3608
25. Lewis J., Burstein E., Birkey Reffey S., Bratton S.B., Roberts A.B., and Duckett C.S. Uncoupling of the signaling and caspase-inhibitory properties of XIAP. J. Biol. Chem. 279 (2004) 9023-9029
26. Mufti A.R., Burstein E., Csomos R.A., Graf P.C., Wilkinson J.C., Dick R.D., Challa M., Son J.K., Bratton S.B., Su G.L., Brewer G.J., Jakob U., and Duckett C.S. XIAP Is a copper binding protein deregulated in Wilson's disease and other copper toxicosis disorders. Mol. Cell 21 (2006) 775-785
27. Yang Y., Fang S., Jensen J.P., Weissman A.M., and Ashwell J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288 (2000) 874-877
28. Rumble J.M., Bertrand M.J., Csomos R.A., Wright C.W., Albert L., Mak T.W., Barker P.A., and Duckett C.S. Apoptotic sensitivity of murine IAP-deficient cells. Biochem. J. 415 (2008) 21-25
29. Stevenson P.G., and Efstathiou S. Immune mechanisms in murine gammaherpesvirus-68 infection. Viral Immunol. 18 (2005) 445-456
30. Bratton S.B., Lewis J., Butterworth M., Duckett C.S., and Cohen G.M. XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95- and Bax-induced apoptosis. Cell Death Differ. 9 (2002) 881-892